Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Semin Nucl Med

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    November 2017
  1. DONDI M, Torres L, Marengo M, Massardo T, et al
    Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine Program. Part 2: Analysis of Results.
    Semin Nucl Med. 2017;47:687-693.
    PubMed     Text format     Abstract available


  2. DONDI M, Torres L, Marengo M, Massardo T, et al
    Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine (QUANUM) Program. Part 1: the QUANUM Program and Methodology.
    Semin Nucl Med. 2017;47:680-686.
    PubMed     Text format     Abstract available


  3. WALDMAN LE, Scharf SC
    Bone SPECT/CT of the Spine, Foot, and Ankle: Evaluation of Surgical Patients.
    Semin Nucl Med. 2017;47:639-646.
    PubMed     Text format     Abstract available


  4. PALESTRO CJ, Love C
    Role of Nuclear Medicine for Diagnosing Infection of Recently Implanted Lower Extremity Arthroplasties.
    Semin Nucl Med. 2017;47:630-638.
    PubMed     Text format     Abstract available


  5. GARG G, Benchekroun MT, Abraham T
    FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls.
    Semin Nucl Med. 2017;47:579-594.
    PubMed     Text format     Abstract available


    September 2017
  6. MATHIS CA, Lopresti BJ, Ikonomovic MD, Klunk WE, et al
    Small-molecule PET Tracers for Imaging Proteinopathies.
    Semin Nucl Med. 2017;47:553-575.
    PubMed     Text format     Abstract available


  7. KILBOURN MR
    Small Molecule PET Tracers for Transporter Imaging.
    Semin Nucl Med. 2017;47:536-552.
    PubMed     Text format     Abstract available


  8. MACH RH
    Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors.
    Semin Nucl Med. 2017;47:524-535.
    PubMed     Text format     Abstract available


  9. JACKSON IM, Scott PJH, Thompson S
    Clinical Applications of Radiolabeled Peptides for PET.
    Semin Nucl Med. 2017;47:493-523.
    PubMed     Text format     Abstract available


  10. SCHIRRMACHER R, Wangler B, Bailey J, Bernard-Gauthier V, et al
    Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers.
    Semin Nucl Med. 2017;47:474-492.
    PubMed     Text format     Abstract available


  11. DONNELLY DJ
    Small Molecule PET Tracers in Drug Discovery.
    Semin Nucl Med. 2017;47:454-460.
    PubMed     Text format     Abstract available


  12. VAVERE AL, Scott PJH
    Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook.
    Semin Nucl Med. 2017;47:429-453.
    PubMed     Text format     Abstract available


    July 2017
  13. KUBOTA K, Yamashita H, Mimori A
    Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.
    Semin Nucl Med. 2017;47:408-424.
    PubMed     Text format     Abstract available


  14. VAN DER BRUGGEN W, Glaudemans AWJM, Vellenga E, Slart RHJA, et al
    PET in Benign Bone Marrow Disorders.
    Semin Nucl Med. 2017;47:397-407.
    PubMed     Text format     Abstract available


  15. ROHREN EM, Macapinlac HA
    Spectrum of Benign Bone Conditions on NaF-PET.
    Semin Nucl Med. 2017;47:392-396.
    PubMed     Text format     Abstract available


  16. PARGHANE RV, Basu S
    Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations.
    Semin Nucl Med. 2017;47:373-391.
    PubMed     Text format     Abstract available


  17. PARIDA GK, Roy SG, Kumar R
    FDG-PET/CT in Skeletal Muscle: Pitfalls and Pathologies.
    Semin Nucl Med. 2017;47:362-372.
    PubMed     Text format     Abstract available


  18. METSER U, Tau N
    Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.
    Semin Nucl Med. 2017;47:352-361.
    PubMed     Text format     Abstract available


  19. ADAMS HJA, Kwee TC
    Guest Editorial on PET of Benign Musculoskeletal Conditions.
    Semin Nucl Med. 2017;47:320-321.
    PubMed     Text format    


    May 2017
  20. PELLETIER-GALARNEAU M, Martineau P, Zuckier LS, Pham X, et al
    18F-FDG-PET/CT Imaging of Thoracic and Extrathoracic Tuberculosis in Children.
    Semin Nucl Med. 2017;47:304-318.
    PubMed     Text format     Abstract available


  21. SIGNORE A, Glaudemans AWJM, Gheysens O, Lauri C, et al
    Nuclear Medicine Imaging in Pediatric Infection or Chronic Inflammatory Diseases.
    Semin Nucl Med. 2017;47:286-303.
    PubMed     Text format     Abstract available


  22. PARISI MT, Bermo MS, Alessio AM, Sharp SE, et al
    Optimization of Pediatric PET/CT.
    Semin Nucl Med. 2017;47:258-274.
    PubMed     Text format     Abstract available


  23. KLUGE R, Kurch L, Georgi T, Metzger M, et al
    Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma.
    Semin Nucl Med. 2017;47:242-257.
    PubMed     Text format     Abstract available


  24. HARRISON DJ, Parisi MT, Shulkin BL
    The Role of 18F-FDG-PET/CT in Pediatric Sarcoma.
    Semin Nucl Med. 2017;47:229-241.
    PubMed     Text format     Abstract available


  25. MENDICHOVSZKY I, Solar BT, Smeulders N, Easty M, et al
    Nuclear Medicine in Pediatric Nephro-Urology: An Overview.
    Semin Nucl Med. 2017;47:204-228.
    PubMed     Text format     Abstract available


  26. DRUBACH LA
    Nuclear Medicine Techniques in Pediatric Bone Imaging.
    Semin Nucl Med. 2017;47:190-203.
    PubMed     Text format     Abstract available


  27. BAR-SEVER Z
    Scintigraphic Evaluation of Gastroesophageal Reflux and Pulmonary Aspiration in Children.
    Semin Nucl Med. 2017;47:275-285.
    PubMed     Text format     Abstract available


    March 2017
  28. MILANESI O, Stellin G, Zucchetta P
    Nuclear Medicine in Pediatric Cardiology.
    Semin Nucl Med. 2017;47:158-169.
    PubMed     Text format     Abstract available


  29. KELLER-PETROT I, Leger J, Sergent-Alaoui A, de Labriolle-Vaylet C, et al
    Congenital Hypothyroidism: Role of Nuclear Medicine.
    Semin Nucl Med. 2017;47:135-142.
    PubMed     Text format     Abstract available


  30. FAHEY FH, Goodkind AB, Plyku D, Khamwan K, et al
    Dose Estimation in Pediatric Nuclear Medicine.
    Semin Nucl Med. 2017;47:118-125.
    PubMed     Text format     Abstract available


  31. GELFAND MJ, Clements C, MacLean JR
    Nuclear Medicine Procedures in Children: Special Considerations.
    Semin Nucl Med. 2017;47:110-117.
    PubMed     Text format     Abstract available


  32. BIELSA IR
    Pediatric Nuclear Medicine and its Development as a Specialty.
    Semin Nucl Med. 2017;47:102-109.
    PubMed     Text format     Abstract available


  33. PFLUGER T, Piccardo A
    Neuroblastoma: MIBG Imaging and New Tracers.
    Semin Nucl Med. 2017;47:143-157.
    PubMed     Text format     Abstract available


    January 2017
  34. HERHOLZ K
    Brain Tumors: An Update on Clinical PET Research in Gliomas.
    Semin Nucl Med. 2017;47:5-17.
    PubMed     Text format     Abstract available


  35. THEODORE WH
    Presurgical Focus Localization in Epilepsy: PET and SPECT.
    Semin Nucl Med. 2017;47:44-53.
    PubMed     Text format     Abstract available


  36. GUNN RN, Rabiner EA
    Imaging in Central Nervous System Drug Discovery.
    Semin Nucl Med. 2017;47:89-98.
    PubMed     Text format     Abstract available


  37. TRIFILIEFF P, Ducrocq F, van der Veldt S, Martinez D, et al
    Blunted Dopamine Transmission in Addiction: Potential Mechanisms and Implications for Behavior.
    Semin Nucl Med. 2017;47:64-74.
    PubMed     Text format     Abstract available


  38. MALLIK A, Drzezga A, Minoshima S
    Clinical Amyloid Imaging.
    Semin Nucl Med. 2017;47:31-43.
    PubMed     Text format     Abstract available


    November 2016
  39. LINDENBERG L, Ahlman M, Turkbey B, Mena E, et al
    Advancement of MR and PET/MR in Prostate Cancer.
    Semin Nucl Med. 2016;46:536-543.
    PubMed     Text format     Abstract available


  40. BOUCHELOUCHE K, Turkbey B, Choyke PL
    PSMA PET and Radionuclide Therapy in Prostate Cancer.
    Semin Nucl Med. 2016;46:522-535.
    PubMed     Text format     Abstract available


  41. SCHUSTER DM, Nanni C, Fanti S
    PET Tracers Beyond FDG in Prostate Cancer.
    Semin Nucl Med. 2016;46:507-521.
    PubMed     Text format     Abstract available


  42. JADVAR H
    Is There Use for FDG-PET in Prostate Cancer?
    Semin Nucl Med. 2016;46:502-506.
    PubMed     Text format     Abstract available


  43. LANGSTEGER W, Rezaee A, Pirich C, Beheshti M, et al
    18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.
    Semin Nucl Med. 2016;46:491-501.
    PubMed     Text format     Abstract available


  44. JALILIAN AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, et al
    Erratum to "Evaluation of Osseous Metastasis in Bone Scintigraphy" [Semin Nucl Med 46 (2016) 340-358].
    Semin Nucl Med. 2016;46:481.
    PubMed     Text format    


    September 2016
  45. HOFMAN MS, Hicks RJ
    Gallium-68 EDTA PET/CT for Renal Imaging.
    Semin Nucl Med. 2016;46:448-61.
    PubMed     Text format     Abstract available


  46. VORSTER M, Maes A, Wiele Cv, Sathekge M, et al
    Gallium-68 PET: A Powerful Generator-based Alternative to Infection and Inflammation Imaging.
    Semin Nucl Med. 2016;46:436-47.
    PubMed     Text format     Abstract available


  47. BAILEY DL, Eslick EM, Schembri GP, Roach PJ, et al
    (68)Ga PET Ventilation and Perfusion Lung Imaging-Current Status and Future Challenges.
    Semin Nucl Med. 2016;46:428-35.
    PubMed     Text format     Abstract available


  48. EO JS, Jeong JM
    Angiogenesis Imaging Using (68)Ga-RGD PET/CT: Therapeutic Implications.
    Semin Nucl Med. 2016;46:419-27.
    PubMed     Text format     Abstract available


  49. KRATOCHWIL C, Afshar-Oromieh A, Kopka K, Haberkorn U, et al
    Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.
    Semin Nucl Med. 2016;46:405-18.
    PubMed     Text format     Abstract available


    July 2016
  50. ELGAZZAR AH, Owunwanne A, Alenezi S
    Structure and Activities of Nuclear Medicine in Kuwait.
    Semin Nucl Med. 2016;46:359-67.
    PubMed     Text format     Abstract available


  51. JALILIAN AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, et al
    Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
    Semin Nucl Med. 2016;46:340-58.
    PubMed     Text format     Abstract available


  52. KIRATLI PO, Tuncel M, Bar-Sever Z
    Nuclear Medicine in Pediatric and Adolescent Tumors.
    Semin Nucl Med. 2016;46:308-23.
    PubMed     Text format     Abstract available


  53. ERGUN EL, Saygi S, Yalnizoglu D, Oguz KK, et al
    SPECT-PET in Epilepsy and Clinical Approach in Evaluation.
    Semin Nucl Med. 2016;46:294-307.
    PubMed     Text format     Abstract available


  54. PAEZ D, Becic T, Bhonsle U, Jalilian AR, et al
    Current Status of Nuclear Medicine Practice in the Middle East.
    Semin Nucl Med. 2016;46:265-72.
    PubMed     Text format     Abstract available


    May 2016
  55. FREEMAN LM, Blaufox MD
    Letter From the Editors.
    Semin Nucl Med. 2016;46:181.
    PubMed     Text format    


    March 2016
  56. MOADEL RM
    Letter From the Guest Editor.
    Semin Nucl Med. 2016;46:98.
    PubMed     Text format    


  57. FREEMAN LM, Blaufox MD
    Letter From the Editors.
    Semin Nucl Med. 2016;46:97.
    PubMed     Text format    


    January 2016
  58. AREVALO-PEREZ J, Paris M, Graham MM, Osborne JR, et al
    A Perspective of the Future of Nuclear Medicine Training and Certification.
    Semin Nucl Med. 2016;46:88-96.
    PubMed     Text format     Abstract available


  59. EISENMENGER LB, Huo EJ, Hoffman JM, Minoshima S, et al
    Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia.
    Semin Nucl Med. 2016;46:57-87.
    PubMed     Text format     Abstract available


  60. PLACZEK MS, Zhao W, Wey HY, Morin TM, et al
    PET Neurochemical Imaging Modes.
    Semin Nucl Med. 2016;46:20-7.
    PubMed     Text format     Abstract available


  61. SLOMKA PJ, Pan T, Germano G
    Recent Advances and Future Progress in PET Instrumentation.
    Semin Nucl Med. 2016;46:5-19.
    PubMed     Text format     Abstract available


  62. DI GIALLEONARDO V, Wilson DM, Keshari KR
    The Potential of Metabolic Imaging.
    Semin Nucl Med. 2016;46:28-39.
    PubMed     Text format     Abstract available


  63. OSBORNE JR
    Guest Editorial.
    Semin Nucl Med. 2016;46:3-4.
    PubMed     Text format    


  64. FREEMAN LM, Blaufox MD
    Letter from the Editors.
    Semin Nucl Med. 2016;46:1-2.
    PubMed     Text format    


    July 2015
  65. FREEMAN L, Blaufox MD
    The potential application of PET/MRI to clinical Nuclear Medicine.
    Semin Nucl Med. 2015;45:267.
    PubMed     Text format    


    May 2015
  66. VON SCHULTHESS GK, Veit-Haibach P
    Guest editorial.
    Semin Nucl Med. 2015;45:189-91.
    PubMed     Text format    


  67. FREEMAN LM, Blaufox MD
    Editorial.
    Semin Nucl Med. 2015;45:187-8.
    PubMed     Text format    


    March 2015
  68. CARLIN S, Humm J
    Hypoxia imaging. Guest editorial.
    Semin Nucl Med. 2015;45:98-100.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: